Back

Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment

2026-02-22 oncology Title + abstract only
View on medRxiv
Show abstract

Gastrointestinal (GI) polyposis is a major risk factor for colorectal cancer (CRC) and a defining feature of hereditary polyposis syndromes such as familial adenomatous polyposis (FAP). Therapy-associated polyposis (TAP), however, is a rare and incompletely characterized condition that develops decades after treatment for childhood or young adult cancers (CYAC), most often following abdominopelvic radiation or exposure to alkylating agents. As long-term CYAC survival improves, the burden of late...

Predicted journal destinations

1
Cancers
57 training papers
Top 0.4% 22.0%
2
Nature Communications
483 training papers
Top 5% 14.4%
3
eLife
262 training papers
Top 5% 5.9%
4
Clinical Cancer Research
22 training papers
Top 1% 5.9%
5
Frontiers in Oncology
34 training papers
Top 3% 5.0%
6
Cancer Medicine
17 training papers
Top 1% 3.8%
7
Scientific Reports
701 training papers
Top 67% 3.8%
8
British Journal of Cancer
22 training papers
Top 2% 3.8%
9
PLOS ONE
1737 training papers
Top 90% 2.8%
10
Proceedings of the National Academy of Sciences
100 training papers
Top 4% 2.1%
11
iScience
74 training papers
Top 3% 1.9%
12
Nature
58 training papers
Top 1% 1.9%
13
Genome Medicine
56 training papers
Top 5% 1.9%
14
Nature Genetics
72 training papers
Top 6% 1.9%
15
Cell Reports
25 training papers
Top 0.2% 1.9%
16
BMC Cancer
21 training papers
Top 4% 1.5%
17
Gut
17 training papers
Top 1% 1.3%
18
Journal of Clinical Investigation
50 training papers
Top 3% 1.3%
19
JAMA Network Open
125 training papers
Top 20% 1.2%
20
Cell Reports Medicine
49 training papers
Top 5% 0.9%
21
Communications Biology
36 training papers
Top 3% 0.9%
22
The Journal of Molecular Diagnostics
24 training papers
Top 3% 0.7%
23
Human Genetics and Genomics Advances
39 training papers
Top 7% 0.7%
24
Nature Medicine
88 training papers
Top 18% 0.7%
25
International Journal of Cancer
18 training papers
Top 2% 0.7%